Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Nanoparticle targeted gene therapy

Targeting genes to certain cells, specifically endothelial cells, hasn't been easy. However, researchers from The Scripps Research Institute last week published data in Science showing the use of a nanoparticle coupled to an integrin ligand to deliver a mutant Raf kinase gene

Read the full 423 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers